Pasithea Effective Tax Rate from 2010 to 2024

KTTAW Stock  USD 0.02  0.00  0.00%   
Pasithea Therapeutics Effective Tax Rate yearly trend continues to be fairly stable with very little volatility. Effective Tax Rate will likely drop to 0.07 in 2024. During the period from 2010 to 2024, Pasithea Therapeutics Effective Tax Rate regression line of quarterly data had r-squared of  0.58 and coefficient of variation of  59.57. View All Fundamentals
 
Effective Tax Rate  
First Reported
2010-12-31
Previous Quarter
0.0726
Current Value
0.069
Quarterly Volatility
0.66339564
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pasithea Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pasithea Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 680.9 K, Other Operating Expenses of 9.9 M or Total Operating Expenses of 9.8 M, as well as many indicators such as Price To Sales Ratio of 36.39, Dividend Yield of 0.0 or PTB Ratio of 0.38. Pasithea financial statements analysis is a perfect complement when working with Pasithea Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Pasithea Therapeutics Correlation against competitors.

Latest Pasithea Therapeutics' Effective Tax Rate Growth Pattern

Below is the plot of the Effective Tax Rate of Pasithea Therapeutics Corp over the last few years. Effective Tax Rate is the average rate at which Pasithea Therapeutics pre-tax profits are taxed by the government. The effective tax rate is computed by dividing Pasithea Therapeutics total tax expenses by Pasithea Therapeutics earnings before taxes. It is Pasithea Therapeutics' Effective Tax Rate historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pasithea Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Effective Tax Rate10 Years Trend
Slightly volatile
   Effective Tax Rate   
       Timeline  

Pasithea Effective Tax Rate Regression Statistics

Arithmetic Mean1.11
Coefficient Of Variation59.57
Mean Deviation0.57
Median1.50
Standard Deviation0.66
Sample Variance0.44
Range1.5002
R-Value(0.76)
Mean Square Error0.20
R-Squared0.58
Significance0.0009
Slope(0.11)
Total Sum of Squares6.16

Pasithea Effective Tax Rate History

2024 0.069
2023 0.0726
2022 0.0631
2021 -2.34E-4

About Pasithea Therapeutics Financial Statements

Pasithea Therapeutics investors use historical fundamental indicators, such as Pasithea Therapeutics' Effective Tax Rate, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pasithea Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Effective Tax Rate 0.07  0.07 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.